{"DataElement":{"publicId":"4250492","version":"1","preferredName":"Neoplasm Soft Tissue Sarcoma Diagnosis Category","preferredDefinition":"Classification, scientific determination, investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms and study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs related to of tissue growth resulting from uncontrolled cell proliferation.","longName":"STSDxCat","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"4250491","version":"1","preferredName":"Neoplasm Soft Tissue Sarcoma Diagnosis","preferredDefinition":"Information related to the scientific determination and investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms of tissue growth resulting from uncontrolled cell proliferation.","longName":"STSDx","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2404687","version":"1","preferredName":"Neoplasm","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0094ACAF-11BC-1BCA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-12","modifiedBy":"ONEDATA","dateModified":"2005-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4250489","version":"1","preferredName":"Soft Tissue Sarcoma Diagnosis","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C9306:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E272-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E283-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4250432","version":"1","preferredName":"STS Tumor Histology Category","preferredDefinition":"Classification of the study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","longName":"STSTmrHistCat","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Undifferentiated sarcoma NOS","valueDescription":"Undifferentiated sarcoma NOS","ValueMeaning":{"publicId":"4250433","version":"1","preferredName":"Undifferentiated sarcoma NOS","longName":"4250433","preferredDefinition":"Undifferentiated sarcoma NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DBF3-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DC0C-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Undifferentiated spindle cell sarcoma","valueDescription":"Undifferentiated spindle cell sarcoma","ValueMeaning":{"publicId":"2568889","version":"1","preferredName":"Undifferentiated spindle cell sarcoma","longName":"2568889","preferredDefinition":"Undifferentiated spindle cell sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA26-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-30","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DC16-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Undifferentiated epithelioid sarcoma","valueDescription":"Undifferentiated epithelioid sarcoma","ValueMeaning":{"publicId":"4250434","version":"1","preferredName":"Undifferentiated epithelioid sarcoma","longName":"4250434","preferredDefinition":"Undifferentiated epithelioid sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DC20-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DC39-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Undifferentiated pleomorphic sarcoma","valueDescription":"Undifferentiated pleomorphic sarcoma","ValueMeaning":{"publicId":"4250435","version":"1","preferredName":"Undifferentiated pleomorphic sarcoma","longName":"4250435","preferredDefinition":"Undifferentiated pleomorphic sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DC43-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DC5C-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Undifferentiated round cell sarcoma","valueDescription":"Undifferentiated round cell sarcoma","ValueMeaning":{"publicId":"4250436","version":"1","preferredName":"Undifferentiated round cell sarcoma","longName":"4250436","preferredDefinition":"Undifferentiated round cell sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DC66-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DC7F-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Embryonal sarcoma (undifferentiated sarcoma) of the liver","valueDescription":"Embryonal sarcoma (undifferentiated sarcoma) of the liver","ValueMeaning":{"publicId":"4250437","version":"1","preferredName":"Embryonal sarcoma (undifferentiated sarcoma) of the liver","longName":"4250437","preferredDefinition":"Embryonal sarcoma (undifferentiated sarcoma) of the liver","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DC89-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DCA2-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Intimal sarcoma","valueDescription":"Intimal Sarcoma","ValueMeaning":{"publicId":"3123928","version":"1","preferredName":"Intimal Sarcoma","longName":"3123928","preferredDefinition":"A malignant neoplasm arising from the large blood vessels.  It is characterized by the presence of tumor cells that grow within the lumen of the blood vessels.  The intraluminal tumor growth may result in vascular obstruction and spread of tumor emboli to peripheral organs.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intimal Sarcoma","conceptCode":"C53677","definition":"A malignant neoplasm arising from the large blood vessels.  It is characterized by the presence of tumor cells that grow within the lumen of the blood vessels.  The intraluminal tumor growth may result in vascular obstruction and spread of tumor emboli to peripheral organs.  The prognosis is usually poor.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4538-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DCB6-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Neoplasms with perivascular epithelioid cell differentiation (PEComa)","valueDescription":"Neoplasms with perivascular epithelioid cell differentiation (PEComa)","ValueMeaning":{"publicId":"4250438","version":"1","preferredName":"Neoplasms with perivascular epithelioid cell differentiation (PEComa)","longName":"4250438","preferredDefinition":"Neoplasms with perivascular epithelioid cell differentiation (PEComa)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DCC0-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DCD9-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Extra-renal rhabdoid tumor","valueDescription":"Extra-renal rhabdoid tumor","ValueMeaning":{"publicId":"4250439","version":"1","preferredName":"Extra-renal rhabdoid tumor","longName":"4250439","preferredDefinition":"Extra-renal rhabdoid tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DCE3-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DCFC-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Desmoplastic small round cell tumor","valueDescription":"Desmoplastic Small Round Cell Tumor","ValueMeaning":{"publicId":"3179342","version":"1","preferredName":"Desmoplastic Small Round Cell Tumor","longName":"3179342","preferredDefinition":"An aggressive malignant neoplasm of uncertain lineage.  It is characterized by the presence of small round cells in a desmoplastic stroma.  It usually affects children and young adults.  The most common site of involvement is the abdomen.  Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic Small Round Cell Tumor","conceptCode":"C8300","definition":"An aggressive malignant soft tissue neoplasm of uncertain differentiation.  It is characterized by a recurrent chromosomal translocation t(11;22)(p13;q12) and the presence of small round cells in a desmoplastic stroma.  It usually affects children and young adults.  The most common site of involvement is the abdomen.  Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass.  The prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-8341-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DD10-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Extraskeletal Ewing sarcoma","valueDescription":"Extraskeletal Ewing sarcoma","ValueMeaning":{"publicId":"4250440","version":"1","preferredName":"Extraskeletal Ewing sarcoma","longName":"4250440","preferredDefinition":"Extraskeletal Ewing sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DD1A-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DD33-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Extraskeletal myxoid chondrosarcoma","valueDescription":"Extraskeletal myxoid chondrosarcoma","ValueMeaning":{"publicId":"2568837","version":"1","preferredName":"Extraskeletal myxoid chondrosarcoma","longName":"2568837","preferredDefinition":"Extraskeletal myxoid chondrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DD3D-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Clear cell sarcoma of soft tissue","valueDescription":"Clear Cell Sarcoma of Soft Tissue","ValueMeaning":{"publicId":"3179239","version":"1","preferredName":"Clear Cell Sarcoma of Soft Tissue","longName":"3179239","preferredDefinition":"A rare malignant neoplasm with melanocytic differentiation characterized by the presence of polygonal or spindle shaped clear cells. This sarcoma usually affects the tendons and aponeuroses and is associated with a poor prognosis due to recurrences and metastases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Sarcoma of Soft Tissue","conceptCode":"C3745","definition":"A rare malignant neoplasm with melanocytic differentiation characterized by the presence of polygonal or spindle shaped clear cells. This sarcoma usually affects the tendons and aponeuroses and is associated with a poor prognosis due to recurrences and metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CE10-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"ONEDATA","dateModified":"2010-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DD51-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Alveolar soft part sarcoma","valueDescription":"Alveolar soft part sarcoma","ValueMeaning":{"publicId":"2568846","version":"1","preferredName":"Alveolar soft part sarcoma","longName":"2568846","preferredDefinition":"Alveolar soft part sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9FB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DD5B-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Malignant phosphaturic mesenchymal tumour","valueDescription":"Malignant phosphaturic mesenchymal tumour","ValueMeaning":{"publicId":"4250441","version":"1","preferredName":"Malignant phosphaturic mesenchymal tumour","longName":"4250441","preferredDefinition":"Malignant phosphaturic mesenchymal tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DD65-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DD7E-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Myoepithelial carcinoma","valueDescription":"Myoepithelial carcinoma","ValueMeaning":{"publicId":"4250442","version":"1","preferredName":"Myoepithelial carcinoma","longName":"4250442","preferredDefinition":"Myoepithelial carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DD88-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DDA1-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Malignant mixed tumour","valueDescription":"Malignant mixed tumour","ValueMeaning":{"publicId":"4250443","version":"1","preferredName":"Malignant mixed tumour","longName":"4250443","preferredDefinition":"Malignant mixed tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DDAB-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DDC4-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Epithelioid sarcoma","valueDescription":"Epithelioid sarcoma","ValueMeaning":{"publicId":"2568844","version":"1","preferredName":"Epithelioid sarcoma","longName":"2568844","preferredDefinition":"Epithelioid sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DDCE-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Malignant ossifying fibromyxoid tumour","valueDescription":"Malignant ossifying fibromyxoid tumour","ValueMeaning":{"publicId":"4250444","version":"1","preferredName":"Malignant ossifying fibromyxoid tumour","longName":"4250444","preferredDefinition":"Malignant ossifying fibromyxoid tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DDD8-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DDF1-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Synovial sarcoma","valueDescription":"Synovial sarcoma","ValueMeaning":{"publicId":"2568843","version":"1","preferredName":"Synovial sarcoma","longName":"2568843","preferredDefinition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Synovial Sarcoma","conceptCode":"C3400","definition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"CAMPBELB","dateModified":"2007-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DDFB-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Phosphaturic mesenchymal tumour","valueDescription":"Phosphaturic mesenchymal tumour","ValueMeaning":{"publicId":"4250445","version":"1","preferredName":"Phosphaturic mesenchymal tumour","longName":"4250445","preferredDefinition":"Phosphaturic mesenchymal tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DE05-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DE1E-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Myoepithelioma","valueDescription":"Myoepithelioma","ValueMeaning":{"publicId":"4250446","version":"1","preferredName":"Myoepithelioma","longName":"4250446","preferredDefinition":"Myoepithelioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DE28-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DE41-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Mixed Tumour NOS","valueDescription":"Mixed Tumour NOS","ValueMeaning":{"publicId":"4250447","version":"1","preferredName":"Mixed Tumour NOS","longName":"4250447","preferredDefinition":"Mixed Tumour NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DE4B-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DE64-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Ossifying fibromyxoid tumor","valueDescription":"Ossifying Fibromyxoid Tumor","ValueMeaning":{"publicId":"3123913","version":"1","preferredName":"Ossifying Fibromyxoid Tumor","longName":"3123913","preferredDefinition":"A rare soft tissue neoplasm of uncertain lineage characterized by the presence of neoplastic spindle to round cells forming cords in a fibromyxoid stroma.  The lesions are associated with the formation of metaplastic bone.  Most patients present with painless subcutaneous masses.  Recurrences have been reported in a minority of patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ossifying Fibromyxoid Tumor","conceptCode":"C6582","definition":"A rare soft tissue tumor of uncertain lineage characterized by the presence of neoplastic spindle to round cells forming cords in a fibromyxoid stroma.  The lesions are associated with the formation of metaplastic bone.  Most patients present with painless subcutaneous masses.  Recurrences have been reported in a minority of patients.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4409-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DE6E-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Angiomatoid fibrous histiocytoma","valueDescription":"Angiomatoid fibrous histiocytoma","ValueMeaning":{"publicId":"4250448","version":"1","preferredName":"Angiomatoid fibrous histiocytoma","longName":"4250448","preferredDefinition":"Angiomatoid fibrous histiocytoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DE78-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DE91-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Atypical fibroxanthoma","valueDescription":"Atypical Fibroxanthoma","ValueMeaning":{"publicId":"3249521","version":"1","preferredName":"Atypical Fibroxanthoma","longName":"3249521","preferredDefinition":"An intermediate cutaneous fibrohistiocytic neoplasm, characterized by pleomorphic spindle cells, usually affecting the actinic-damaged skin of the elderly.  The tumor presents as a single cutaneous nodule which is often ulcerated.  Microscopically, it is indistinguishable from pleomorphic forms of malignant fibrous histiocytoma, and it is regarded by many experts as a superficial form of the latter.  The vast majority of patients have an excellent prognosis following conservative therapy.  Recurrences are infrequent, and metastasis is rare. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical Fibroxanthoma","conceptCode":"C4246","definition":"An intermediate cutaneous mesenchymal neoplasm of uncertain differentiation, usually affecting the actinic-damaged skin of the elderly.  The tumor presents as a single cutaneous nodule which is often ulcerated.  Microscopically, it is characterized by the presence of highly atypical cytologic features, pleomorphism and abundant mitotic figures. The vast majority of patients have an excellent prognosis following conservative therapy. Recurrences are infrequent, and metastasis is rare.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D8A436-0606-647C-E040-BB89AD435D86","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DEA5-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Ectomesenchymoma","valueDescription":"Ectomesenchymoma","ValueMeaning":{"publicId":"4250449","version":"1","preferredName":"Ectomesenchymoma","longName":"4250449","preferredDefinition":"Ectomesenchymoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DEAF-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DEC8-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Malignant granular cell tumor","valueDescription":"Malignant granular cell tumor","ValueMeaning":{"publicId":"4250450","version":"1","preferredName":"Malignant granular cell tumor","longName":"4250450","preferredDefinition":"Malignant granular cell tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DED2-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DEEB-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Malignant Triton tumour","valueDescription":"Malignant Triton tumour","ValueMeaning":{"publicId":"4250451","version":"1","preferredName":"Malignant Triton tumour","longName":"4250451","preferredDefinition":"Malignant Triton tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DEF5-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DF0E-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Epithelioid malignant peripheral nerve sheath tumour","valueDescription":"Epithelioid malignant peripheral nerve sheath tumour","ValueMeaning":{"publicId":"4250452","version":"1","preferredName":"Epithelioid malignant peripheral nerve sheath tumour","longName":"4250452","preferredDefinition":"Epithelioid malignant peripheral nerve sheath tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DF18-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DF31-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Malignant peripheral nerve sheath tumor","valueDescription":"Malignant peripheral nerve sheath tumor","ValueMeaning":{"publicId":"2568830","version":"1","preferredName":"Malignant peripheral nerve sheath tumor","longName":"2568830","preferredDefinition":"Malignant peripheral nerve sheath tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9EB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DF3B-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Extraskeletal osteosarcoma","valueDescription":"Extraskeletal osteosarcoma","ValueMeaning":{"publicId":"2568839","version":"1","preferredName":"Extraskeletal osteosarcoma","longName":"2568839","preferredDefinition":"Extraskeletal osteosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DF45-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Mesenchymal chondrosarcoma","valueDescription":"Mesenchymal chondrosarcoma","ValueMeaning":{"publicId":"2568864","version":"1","preferredName":"Mesenchymal chondrosarcoma","longName":"2568864","preferredDefinition":"Mesenchymal chondrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA0D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DF4F-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Angiosarcoma of soft tissue","valueDescription":"Angiosarcoma of soft tissue","ValueMeaning":{"publicId":"4250453","version":"1","preferredName":"Angiosarcoma of soft tissue","longName":"4250453","preferredDefinition":"Angiosarcoma of soft tissue","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DF59-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DF72-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Epithelioid hemangioendothelioma","valueDescription":"Epithelioid Hemangioendothelioma","ValueMeaning":{"publicId":"3179346","version":"1","preferredName":"Epithelioid Hemangioendothelioma","longName":"3179346","preferredDefinition":"A low grade malignant blood vessel neoplasm characterized by the presence of epithelioid endothelial cells, hylanized and myxoid stroma formation, and angiocentricity. It may present as a painful mass.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelioid Hemangioendothelioma","conceptCode":"C3800","definition":"A low-grade malignant blood vessel neoplasm.  It is characterized by the presence of epithelioid endothelial cells.  The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-83D3-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DF7C-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Kaposi sarcoma","valueDescription":"Kaposi sarcoma","ValueMeaning":{"publicId":"2568842","version":"1","preferredName":"Kaposi sarcoma","longName":"2568842","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"UMLLOADER_COPPAPRD","dateModified":"2009-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DF86-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma","valueDescription":"Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma","ValueMeaning":{"publicId":"4250454","version":"1","preferredName":"Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma","longName":"4250454","preferredDefinition":"Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DF90-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DFA9-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Composite hemangioendothelioma","valueDescription":"Composite Hemangioendothelioma","ValueMeaning":{"publicId":"3123863","version":"1","preferredName":"Composite Hemangioendothelioma","longName":"3123863","preferredDefinition":"An intermediate, rarely metastasizing blood vessel neoplasm.  It is characterized by the presence of spindle, plump, and epithelioid endothelial cells and cellular atypia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Composite Hemangioendothelioma","conceptCode":"C45475","definition":"An intermediate, locally aggressive and rarely metastasizing blood vessel neoplasm.  It is characterized by the presence of spindle, plump, and epithelioid endothelial cells and cellular atypia.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-3BC0-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DFBD-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Papillary intralymphatic angioendothelioma","valueDescription":"Papillary Intralymphatic Angioendothelioma","ValueMeaning":{"publicId":"3123911","version":"1","preferredName":"Papillary Intralymphatic Angioendothelioma","longName":"3123911","preferredDefinition":"An intermediate, rarely metastasizing blood vessel neoplasm. It is characterized by the presence of lymphatic-like vascular channels and papillary endothelial proliferation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Intralymphatic Angioendothelioma","conceptCode":"C7526","definition":"An intermediate, rarely metastasizing blood vessel neoplasm. It is characterized by the presence of lymphatic-like vascular channels and papillary endothelial proliferation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-43E3-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DFD1-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Retiform hemangioendothelioma","valueDescription":"Retiform Hemangioendothelioma","ValueMeaning":{"publicId":"3123906","version":"1","preferredName":"Retiform Hemangioendothelioma","longName":"3123906","preferredDefinition":"An intermediate, locally aggressive blood vessel neoplasm.  It is characterized by the presence of hobnail endothelial cells and formation of arborizing vascular channels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retiform Hemangioendothelioma","conceptCode":"C27511","definition":"An intermediate, locally aggressive and rarely metastasizing blood vessel neoplasm.  It is characterized by the presence of hobnail endothelial cells and formation of arborizing vascular channels.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4371-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-DFE5-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Spindle cell/sclerosing rhabdomyosarcoma","valueDescription":"Spindle cell/sclerosing rhabdomyosarcoma","ValueMeaning":{"publicId":"4250455","version":"1","preferredName":"Spindle cell/sclerosing rhabdomyosarcoma","longName":"4250455","preferredDefinition":"Spindle cell/sclerosing rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DFEF-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E008-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Pleomorphic rhabdomyosarcoma","valueDescription":"Pleomorphic rhabdomyosarcoma","ValueMeaning":{"publicId":"2568835","version":"1","preferredName":"Pleomorphic rhabdomyosarcoma","longName":"2568835","preferredDefinition":"Pleomorphic rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E012-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Alveolar rhabdomyosarcoma","valueDescription":"Alveolar rhabdomyosarcoma","ValueMeaning":{"publicId":"2568834","version":"1","preferredName":"Alveolar rhabdomyosarcoma","longName":"2568834","preferredDefinition":"Alveolar rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9EF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E01C-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Embryonal rhabdomyosarcoma","valueDescription":"Embryonal rhabdomyosarcoma","ValueMeaning":{"publicId":"2568831","version":"1","preferredName":"Embryonal rhabdomyosarcoma","longName":"2568831","preferredDefinition":"Embryonal rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9EC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E026-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Malignant glomus tumour","valueDescription":"Malignant glomus tumour","ValueMeaning":{"publicId":"4250456","version":"1","preferredName":"Malignant glomus tumour","longName":"4250456","preferredDefinition":"Malignant glomus tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E030-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E049-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Leiomyosarcoma","valueDescription":"Leiomyosarcoma","ValueMeaning":{"publicId":"3081921","version":"1","preferredName":"Leiomyosarcoma","longName":"3081921","preferredDefinition":"A common malignant mesenchymal neoplasm.  It originates from the smooth muscles, and the most common anatomic sites are the uterus and the gastrointestinal tract.  It is characterized by spindle cell morphology.  Cellular pleomorphism may be present. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leiomyosarcoma","conceptCode":"C3158","definition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women.  It is characterized by a proliferation of neoplastic spindle cells.  Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85C82E27-AE99-B724-E040-BB89AD436170","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E053-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Giant cell tumour of soft tissues","valueDescription":"Giant cell tumour of soft tissues","ValueMeaning":{"publicId":"4250457","version":"1","preferredName":"Giant cell tumour of soft tissues","longName":"4250457","preferredDefinition":"Giant cell tumour of soft tissues","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E05E-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E077-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Plexiform fibrohistiocytic tumour","valueDescription":"Plexiform fibrohistiocytic tumour","ValueMeaning":{"publicId":"4250458","version":"1","preferredName":"Plexiform fibrohistiocytic tumour","longName":"4250458","preferredDefinition":"Plexiform fibrohistiocytic tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E081-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E09A-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Sclerosing epithelioid fibrosarcoma","valueDescription":"Sclerosing Epithelioid Fibrosarcoma","ValueMeaning":{"publicId":"3123904","version":"1","preferredName":"Sclerosing Epithelioid Fibrosarcoma","longName":"3123904","preferredDefinition":"A well-circumscribed rare morphologic variant of fibrosarcoma, that arises from the soft tissues. It is characterized by the presence of nests of malignant epithelioid fibroblasts and sclerotic collagen stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sclerosing Epithelioid Fibrosarcoma","conceptCode":"C49027","definition":"A well-circumscribed malignant fibroblastic neoplasm that usually arises from the soft tissue. It is characterized by the presence of nests of malignant epithelioid fibroblasts and sclerotic collagen stroma formation.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-4336-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E0AE-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Low grade fibromyxoid sarcoma","valueDescription":"Low Grade Fibromyxoid Sarcoma","ValueMeaning":{"publicId":"3123924","version":"1","preferredName":"Low Grade Fibromyxoid Sarcoma","longName":"3123924","preferredDefinition":"denoting slow growth; indolent.: A usually aggressive malignant mesenchymal cell tumor most commonly arising from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels.  Sarcomas occur in both children and adults.  The prognosis depends largely on the degree of differentiation (grade) of the tumor.  Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma. -- 2004: A soft tissue neoplasm of uncertain lineage characterized by the presence of neoplastic spindle-shaped to round cells in a fibromyxoid stroma. Metaplastic bone formation may or may not be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sarcoma","conceptCode":"C9118","definition":"A usually aggressive malignant neoplasm of the soft tissue or bone. It arises from muscle, fat, fibrous tissue, bone, cartilage, and blood vessels. Sarcomas occur in both children and adults. The prognosis depends largely on the degree of differentiation (grade) of the neoplasm. Representative subtypes are liposarcoma, leiomyosarcoma, osteosarcoma, and chondrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fibromyxoid Tumor","conceptCode":"C66760","definition":"A soft tissue tumor of uncertain lineage characterized by the presence of neoplastic spindle-shaped to round cells in a fibromyxoid stroma. Metaplastic bone formation may or may not be present.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-44EC-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E0C2-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Myxofibrosarcoma","valueDescription":"Myxofibrosarcoma","ValueMeaning":{"publicId":"2568826","version":"1","preferredName":"Myxofibrosarcoma","longName":"2568826","preferredDefinition":"Myxofibrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E0CC-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Malignant solitary fibrous tumour","valueDescription":"Malignant solitary fibrous tumour","ValueMeaning":{"publicId":"4250459","version":"1","preferredName":"Malignant solitary fibrous tumour","longName":"4250459","preferredDefinition":"Malignant solitary fibrous tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E0D6-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E0EF-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Adult fibrosarcoma","valueDescription":"Adult fibrosarcoma","ValueMeaning":{"publicId":"4250460","version":"1","preferredName":"Adult fibrosarcoma","longName":"4250460","preferredDefinition":"Adult fibrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E0F9-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E112-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Infantile fibrosarcoma","valueDescription":"Infantile fibrosarcoma","ValueMeaning":{"publicId":"2571010","version":"1","preferredName":"Infantile fibrosarcoma","longName":"2571010","preferredDefinition":"Infantile fibrosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E26F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-07-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-07-07","modifiedBy":"CAMPBELB","dateModified":"2004-07-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E11C-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Atypical myxoinflammatory fibroblastic tumour","valueDescription":"Atypical myxoinflammatory fibroblastic tumour","ValueMeaning":{"publicId":"4250461","version":"1","preferredName":"Atypical myxoinflammatory fibroblastic tumour","longName":"4250461","preferredDefinition":"Atypical myxoinflammatory fibroblastic tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E126-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E13F-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Myxoinflammatory fibroblastic sarcoma","valueDescription":"Myxoinflammatory Fibroblastic Sarcoma","ValueMeaning":{"publicId":"3123915","version":"1","preferredName":"Myxoinflammatory Fibroblastic Sarcoma","longName":"3123915","preferredDefinition":"A low grade multinodular malignant neoplasm arising from the soft tissues.  It is characterized by the presence of spindle-shaped fibroblasts, multivacuolated lipoblast-like cells, bizarre ganglion-like cells with inclusion-like nuclei, myxoid stroma formation, and a mixture of acute and chronic inflammatory infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myxoinflammatory Fibroblastic Sarcoma","conceptCode":"C49025","definition":"A low grade, locally aggressive, fibroblastic neoplasm that occurs primarily in the distal extremities.  It is characterized by the presence of spindle-shaped fibroblasts, multivacuolated lipoblast-like cells, bizarre ganglion-like cells with inclusion-like nuclei, myxoid stroma formation, and a mixture of acute and chronic inflammatory cells.  Distant metastases are very rare.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-442F-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E153-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Low grade myofibroblastic sarcoma","valueDescription":"Low grade myofibroblastic sarcoma","ValueMeaning":{"publicId":"3123922","version":"1","preferredName":"Low grade myofibroblastic sarcoma","longName":"3123922","preferredDefinition":"Low grade myofibroblastic sarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BD13A85-44C4-7057-E040-BB89AD4314E1","latestVersionIndicator":"Yes","beginDate":"2010-07-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E167-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Pigmented dermatofibrosarcoma protuberans","valueDescription":"Pigmented dermatofibrosarcoma protuberans","ValueMeaning":{"publicId":"4250462","version":"1","preferredName":"Pigmented dermatofibrosarcoma protuberans","longName":"4250462","preferredDefinition":"Pigmented dermatofibrosarcoma protuberans","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E171-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E18A-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Fibrosarcomatous dermatofibrosarcoma protuberans","valueDescription":"Fibrosarcomatous dermatofibrosarcoma protuberans","ValueMeaning":{"publicId":"4250463","version":"1","preferredName":"Fibrosarcomatous dermatofibrosarcoma protuberans","longName":"4250463","preferredDefinition":"Fibrosarcomatous dermatofibrosarcoma protuberans","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E194-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E1AD-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Dermatofibrosarcoma protuberans","valueDescription":"Dermatofibrosarcoma protuberans","ValueMeaning":{"publicId":"2568824","version":"1","preferredName":"Dermatofibrosarcoma protuberans","longName":"2568824","preferredDefinition":"Dermatofibrosarcoma protuberans","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E1B7-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Inflammatory myofibroblastic tumour","valueDescription":"Inflammatory myofibroblastic tumour","ValueMeaning":{"publicId":"4250464","version":"1","preferredName":"Inflammatory myofibroblastic tumour","longName":"4250464","preferredDefinition":"Inflammatory myofibroblastic tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E1C1-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E1DA-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Solitary fibrous tumour","valueDescription":"Solitary fibrous tumour","ValueMeaning":{"publicId":"4250465","version":"1","preferredName":"Solitary fibrous tumour","longName":"4250465","preferredDefinition":"Solitary fibrous tumour","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E1E4-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E1FD-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Liposarcoma, not otherwise specified","valueDescription":"Liposarcoma, not otherwise specified","ValueMeaning":{"publicId":"4250466","version":"1","preferredName":"Liposarcoma, not otherwise specified","longName":"4250466","preferredDefinition":"Liposarcoma, not otherwise specified","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E207-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E220-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Pleomorphic liposarcoma","valueDescription":"Pleomorphic liposarcoma","ValueMeaning":{"publicId":"2568822","version":"1","preferredName":"Pleomorphic liposarcoma","longName":"2568822","preferredDefinition":"Pleomorphic liposarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E22A-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Myxoid liposarcoma","valueDescription":"Myxoid liposarcoma","ValueMeaning":{"publicId":"2568821","version":"1","preferredName":"Myxoid liposarcoma","longName":"2568821","preferredDefinition":"Myxoid liposarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E234-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Dedifferentiated liposarcoma","valueDescription":"Dedifferentiated liposarcoma","ValueMeaning":{"publicId":"2568820","version":"1","preferredName":"Dedifferentiated liposarcoma","longName":"2568820","preferredDefinition":"Dedifferentiated liposarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9E1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E23E-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Atypical lipomatous tumour / Well differentiated liposarcoma","valueDescription":"Atypical lipomatous tumour / Well differentiated liposarcoma","ValueMeaning":{"publicId":"4250467","version":"1","preferredName":"Atypical lipomatous tumour / Well differentiated liposarcoma","longName":"4250467","preferredDefinition":"Atypical lipomatous tumour / Well differentiated liposarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E248-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F573C450-E261-DE25-E040-BB89AD432556","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F577784D-331C-FDE5-E040-BB89AD4308BD","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","deletedIndicator":"No"},{"value":"Botryoid rhabdomyosarcoma","valueDescription":"Botryoid rhabdomyosarcoma","ValueMeaning":{"publicId":"2568832","version":"1","preferredName":"Botryoid rhabdomyosarcoma","longName":"2568832","preferredDefinition":"Botryoid rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9ED-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C098A66-3000-A783-E050-BB89AD434722","beginDate":"2015-07-29","endDate":null,"createdBy":"CORRALC","dateCreated":"2015-07-29","modifiedBy":"ONEDATA","dateModified":"2015-07-29","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2960664","version":"1","preferredName":"Unknown","longName":"2960664","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78485FBD-4C65-D67B-E040-BB89AD432E0E","latestVersionIndicator":"Yes","beginDate":"2009-11-13","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-11-13","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1C098A66-300A-A783-E050-BB89AD434722","beginDate":"2015-07-29","endDate":null,"createdBy":"CORRALC","dateCreated":"2015-07-29","modifiedBy":"ONEDATA","dateModified":"2015-07-29","deletedIndicator":"No"},{"value":"Rhabdomyosarcoma, insufficient sample to categorize","valueDescription":"Rhabdomyosarcoma, insufficient sample to categorize","ValueMeaning":{"publicId":"5178212","version":"1","preferredName":"Rhabdomyosarcoma, insufficient sample to categorize","longName":"5178212","preferredDefinition":"Rhabdomyosarcoma, insufficient sample to categorize","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E57B40E-8E51-32A0-E050-BB89AD4318CC","latestVersionIndicator":"Yes","beginDate":"2016-03-18","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E57B40E-8E6A-32A0-E050-BB89AD4318CC","beginDate":"2016-03-18","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-03-18","modifiedBy":"ONEDATA","dateModified":"2016-03-18","deletedIndicator":"No"},{"value":"Mixed rhabdomyosarcoma","valueDescription":"Mixed rhabdomyosarcoma","ValueMeaning":{"publicId":"5178213","version":"1","preferredName":"Mixed rhabdomyosarcoma","longName":"5178213","preferredDefinition":"Mixed rhabdomyosarcoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E57B40E-8E74-32A0-E050-BB89AD4318CC","latestVersionIndicator":"Yes","beginDate":"2016-03-18","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-03-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2E57B40E-8E8D-32A0-E050-BB89AD4318CC","beginDate":"2016-03-18","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-03-18","modifiedBy":"ONEDATA","dateModified":"2016-03-18","deletedIndicator":"No"},{"value":"Rhabdomyosarcoma NOS","valueDescription":"Rhabdomyosarcoma NOS","ValueMeaning":{"publicId":"2568836","version":"1","preferredName":"Rhabdomyosarcoma NOS","longName":"2568836","preferredDefinition":"Rhabdomyosarcoma NOS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C883F0F4-9CAD-11D4-E053-4EBD850AE444","beginDate":"2021-08-02","endDate":null,"createdBy":"MACASAC","dateCreated":"2021-08-02","modifiedBy":"ONEDATA","dateModified":"2021-08-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4250431","version":"1","preferredName":"Histology Category","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.:This term is used informally to mean a class of things.","longName":"C16681:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DBD0-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"ONEDATA","dateModified":"2014-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-DBE1-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"MACASAC","dateModified":"2021-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"STS Tumor Histology:","type":"Preferred Question Text","description":"STS Tumor Histology:","url":null,"context":"COG"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"If RMS, Specify","url":null,"context":"COG"},{"name":"COG CRF TEXT 2","type":"Alternate Question Text","description":"If NRSTS - STS Tumor Histology","url":null,"context":"COG"},{"name":"COG CRF TEXT 3","type":"Alternate Question Text","description":"RMS Histology Type","url":null,"context":"COG"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"If other, specify:","url":null,"context":"COG"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"If mixed, specify percentage of each component:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F573C450-E296-DE25-E040-BB89AD432556","latestVersionIndicator":"Yes","beginDate":"2014-03-25","endDate":null,"createdBy":"TSANE","dateCreated":"2014-03-25","modifiedBy":"DAVISJ","dateModified":"2016-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}